申请人:Hoffmann-La Roche Inc.
公开号:US05387585A1
公开(公告)日:1995-02-07
The novel imidazodiazepine derivatives of the formula: ##STR1## wherein the substituents are as described in the specification, can be used for the control or prevention of epileptic seizures, anxiety, tension and excitation states, sleep disorders, schizophrenic symptoms, hepatic encephalopathy and senile dementia, as well as, in the partial or complete antagonization of undesired side-effects of substances acting on benzodiazepine receptors after over-dosage or after their use in intensive medicine and in anesthesia.
这段话的中文翻译如下:
公式为:##STR1##的新型咪唑二氮平衍生物,其中取代基如规范中所述,可用于控制或预防癫痫发作、焦虑、紧张和兴奋状态、睡眠障碍、精神分裂症状、肝性脑病和老年痴呆症,以及在过量使用或在密集医学和麻醉中使用后,部分或完全对作用于苯二氮平受体的物质产生的不良副作用进行拮抗。